Correlation of plasma concentrations of B-type natriuretic peptide with infarct size quantified by tomographic thallium-201 myocardial scintigraphy in asymptomatic patients with previous myocardial infarction

Circulation Journal

Volumn 68, Issue 10, 2004, Pages 923-927

  Nakagawa, Kazuya ^a   Umetani, Ken ^a   Fujioka, Daisuke ^a   Sano, Keita ^a   Nakamura, Takamitsu ^a   Kodama, Yasushi ^a   Kitta, Yoshinobu ^a   Ichigi, Yoshihide ^a   Kawabata, Ken Ichi ^a   Obata, Jyun Ei ^a   Takano, Hajime ^a   Inobe, Yoshito ^b   Kugiyama, Kiyotaka ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

^b Inobe Hospital   (Japan)

Author keywords

Heart failure; Myocardial infarction; Myocardial scintigraphy; Natriuretic peptides

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; THALLIUM 201;

ADULT; AGED; ARTICLE; CALCULATION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE FUNCTION; HEART SCINTISCANNING; HEMODYNAMICS; HUMAN; JAPAN; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYMPTOM;

ADULT; AGED; AGED, 80 AND OVER; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 6944233418     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.68.923     Document Type: Article

References (23)

1. de Bold AJ. Atrial natriuretic factor. A hormone produced by the heart. Science 1985; 230: 767-770.
2. Yoshimura M, Yasue H, Morita E, Sakaino N, Jougasaki M, Kurose M, et al. Hemodynamic, renal and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure. Circulation 1991; 84: 1581-1588.
3. Saito Y, Nakao K, Arai H, Nishimura K, Okumura K, Obata K, et al. Augmented expression of atrial natriuretic polypeptide gene in ventricle of human failing heart. J Clin Invest 1989; 83: 289-305.
4. Yasue H, Yoshimura M, Sumida H, Kikuta K, Kugiyama K, Jougasaki M, et al. Localization and mechanisms of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 1994; 90: 195-203.
5. Burnett JC, Kao PC, Hu DC, Heser DW, Heublein D, Granger JP, et al. Atrial natriuretic peptide elevation in congestive heart failure in the human. Science 1986; 231: 1145-1147.
6. Sumida H, Yasue H, Yoshimura M, Okumura K, Ogawa H, Kugiyama K, et al. Comparison of secretion pattern between A-type and B-type natriuretic peptides in patients with old myocardial infarction. J Am Coll Cardiol 1995; 25: 1105-1110.
7. Yoshimura M, Mizuno Y, Harada E, Nakayama M, Ho T, Nakamura S, et al. Interaction on metabolic clearance between A-type and B-type natriuretic peptides in patients with heart failure. Metabolism 2000; 49: 1228-1233.
8. Omland T, Aakvaag A, Bonarjee VVS, Caidahl K, Lie RT, Nilsen DWT, et al. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction: Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide. Circulation 1996; 96: 1963-1969.
9. Svanegaard J, Angelo-Nielsen K, Pindborg T. Plasma concentration of atrial natriuretic peptide at admission and risk of cardiac death in patients with acute myocardial infarction. Br Heart J 1992; 68: 38-42.
10. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction: Experimental observations and clinical implications. Circulation 1990; 81: 1161-1172.
11. Maewal P, de Lemos JA. Natriuretic peptide hormone measurement in acute coronary syndromes. Heart Fail Rev 2003; 8: 365-368.
12. Mukoyama M, Nakao K, Hosoda K, Suga S, Saito Y, Ogawa Y, et al. Brain natriuretic peptide (BNP) as a novel cardiac hormone in humans: Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest 1991; 87: 1402-1412.
13. Becker LC, Silverman KJ, Bulkley BH, Kallman CH, Mellits ED, Weisfeldt M. Comparison of early thallium-201 scintigraphy and gated blood pool imaging for predicting mortality in patients with acute myocardial infarction. Circulation 1983; 67: 1272-1282.
14. Hadase M, Azuma A, Zen K, Asada S, Kawasaki T, Kamitani T, et al. Very low frequency power of heart rate variability is a powerful predictor of clinical prognosis in patients with congestive heart failure. Circ J 2004; 68: 343-347.
15. Kugiyama K, Yasue H, Horio Y, Morikami Y, Fujii H, Koga Y, et al. Effect of propranolol and nifedipine on exercise-induced attack in patients with variant angina: Assessment by exercise thallium-201 myocardial scintigraphy with quantitative rotational tomography. Circulation 1986; 74: 374-380.
16. Perez-Gonzalez J, Botvinick EH, Dunn R, Rahimtoola S, Ports T, Chatterjee K, et al. The late prognostic value of acute scintigraphic measurement of myocardial infarction size. Circulation 1982; 66: 960-971.
17. Peterson ED, Shaw LJ, Califf RM. Risk stratification after myocardial infarction. Ann Intern Med 1997; 126: 561-582.
18. Jougasaki M, Yasue H, Mukoyama M, Nakao K, Takahashi K. Appearance of atrial natriurtic peptide in the ventricles in patients with myocardial infarction. Am Heart J 1990; 119: 92-96.
19. Hama N, Itoh H, Shirakami G, Nakagawa O, Suga S, Ogawa Y, et al. Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction. Circulation 1995; 92: 1558-1564.
20. Yoshimura M, Yasue H, Okumura K, Ogawa H, Jougasaki M, Mukoyama M, et al. Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure. Circulation 1993; 87: 464-469.
21. Ogawa K, Oida A, Sugimura H, Kaneko N, Nogi N, Hasumi M, et al. Clinical significance of blood brain natriuretic peptide level measurement in the detection of heart disease in untreated outpatients: Comparison of electrocardiography, chest radiography and echocardiography. Circ J 2002; 66: 122-126.
22. Yasumura Y, Miyatake K, Okamoto H, Miyauchi T, Kawana M, Tsutamoto T, et al. Rationale for the use of combination angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker therapy in heart failure. Circ J 2004; 68: 361-366.
23. Christian TF, O'Connor MK, Hopfenspirger MR, Gibbons RJ. Comparison of reinjection thallium 201 and resting technetium 99m sestamibi tomographic images for the quantification of infarct size after acute myocardial infarction. J Nucl Cardiol 1994; 1: 17-28.